Eli Lilly’s Tirzepatide Gains Market Share
Eli Lilly’s Tirzepatide Gains Market Share
Editor’s note: The headline and body of this story have been update to correct the name of Eli Lilly’s drug tirzepatide. In support of expectations for Eli Lilly And Company LLY‘s tirzepatide, BMO Capital Markets is tracking weekly Mounjaro, Zepbound, GLP-1 category TRx (total prescriptions), …